| 000 | 01438 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250512025334.0 | ||
| 264 | 0 | _c19861010 | |
| 008 | 198610s 0 0 eng d | ||
| 022 | _a0163-4453 | ||
| 024 | 7 |
_a10.1016/s0163-4453(86)92698-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYamamoto, S | |
| 245 | 0 | 0 |
_aComparison of results for phase I studies with recombinant and plasma-derived hepatitis B vaccines, and controlled study comparing intramuscular and subcutaneous injections of recombinant hepatitis B vaccine. _h[electronic resource] |
| 260 |
_bThe Journal of infection _cJul 1986 |
||
| 300 |
_a53-60 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis B Antibodies _xanalysis |
| 650 | 0 | 4 | _aHepatitis B Vaccines |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aVaccination |
| 650 | 0 | 4 |
_aViral Hepatitis Vaccines _xadministration & dosage |
| 700 | 1 | _aKuroki, T | |
| 700 | 1 | _aKurai, K | |
| 700 | 1 | _aIino, S | |
| 773 | 0 |
_tThe Journal of infection _gvol. 13 Suppl A _gp. 53-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0163-4453(86)92698-8 _zAvailable from publisher's website |
| 999 |
_c2949658 _d2949658 |
||